deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT04455178

The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure (SIRRHF)

Sponsor: Shanghai Jiao Tong University School of Medicine

Conditions Hypertension
Interventions Indapamide Spironolactone
Updated 8 times since 2020 Last updated: Dec 7, 2021 Started: Sep 23, 2020 Primary completion: Dec 31, 2023 Completion: Dec 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hypertension, this trial is ongoing. The trial is conducted by Shanghai Jiao Tong University School of Medicine and has accumulated 8 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshotNot Yet Recruiting~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotRecruiting~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotRecruiting~Jan 2022 – ~Feb 2024 · 25 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Feb 2024 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

  4. Jan 2022 — Feb 2024 [monthly]

    Recruiting PHASE4

  5. Jan 2021 — Jan 2022 [monthly]

    Recruiting PHASE4

▶ Show 3 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  2. Sep 2020 — Nov 2020 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  3. Aug 2020 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shanghai Jiao Tong University School of Medicine
Data source: Shanghai Jiao Tong University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations